Home / News / India News / Article /
SII seeks nod to export 32.4 lakh doses of its Covid vaccine Covovax to US
Updated On: 30 June, 2022 05:22 PM IST | New Delhi | PTI
On December 28, 2021, the Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults, and in the 12-17 year age group on March 9 this year

Representative image. Pic/Istock
The Serum Institute has sought the Centre's approval to export 32.4 lakh doses of the Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any Indian manufacturer, official sources said on Thursday.
According to a communication sent to the government by Prakash Kumar Singh, Director, Government and Regulatory Affairs at the SII, the shipment is likely to be dispatched on July 3 if due approval come in time, an official source told PTI.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

